Evaluation of PDGF-AB and sP-selectin concentrations in relation to platelet count in patients with colorectal cancer before and after surgical treatment

Polskie Archiwum Medycyny Wewnetrznej

Volumn 118, Issue 6, 2008, Pages 345-350

  Mantur, Maria ^a,c   Koper, Olga ^a   Snarska, Jadwiga ^a   Sidorska, Anna ^b   Kruszewska Wnorowska, Katarzyna ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b Department of Gynecology and Obstetrics   (Poland)

^c Samodzielny Publiczny Dzieci cy Szpital Kliniczny   (Poland)

Author keywords

Colorectal cancer; PDGF AB; sP selectin

Indexed keywords

PADGEM PROTEIN; PLATELET DERIVED GROWTH FACTOR AB;

ADULT; ARTICLE; BLOOD SAMPLING; CANCER PATIENT; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HEMATOLOGICAL PARAMETERS; HUMAN; MALE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; SURGICAL PATIENT; THROMBOCYTE COUNT;

EID: 46949101771     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: 10.20452/pamw.410     Document Type: Article

References (25)

1. Dell S, Peters S, Müther P, et al. The role of PDGF receptor inhibitors and PI3-kinase signalling in the pathogenesis of corneal neovascularization. Invest Ophthalmol Vis Sci. 2006; 47: 1928-1937.
2. Nowak MM, Mucha K, Foroncewicz B. Znaczenie PDGF w patogenezie wybranych jednostek chorobowych. Pol Arch Med Wew. 2005; 6: 603-608.
3. Ay C, Jungbauer LV, Sailer T. High concentration of soluble P-selectin are associated with risk of venous thromboembolism and the P-selectin Thr715 variant. Clin Chem. 2007; 53: 1235-1243.
4. Miller-Kasprzak E, Niemir ZI, Czekalski S. Rola płytkopochodnego czynnika wzrostu A (PDGF-A) w nadciśnieniu tȩtniczym i chorobach nerek. Cz. 1. Budowa i regulacja ekspresji genu PDGF-A i jego rola w nadciśnieniu tȩtniczym. Pol Merk Lek. 2004; 94: 398-401.
5. Kim HR, Upadhyay S, Korsmeyer S, et al. Platelets-derived growth factor (PDGF) B and A homodimers transform murine fibroblasts depending on the genetic background of the cell. J Biol Chem. 1994, 269: 30604-30608.
6. Sundberg C, Branting M, Gerdin B, et al. Tumour cell and connective tissue cell interactions in human colorectal adenocarcinoma. Transfer of platelets-derived growth factor-AB/BB to stromal cells. Am J Pathol. 1997; 151: 479-492.
7. Heldin CH, Ostman A, Ronnstrand L. Signal transduction via platelets-derived growth factor receptors. Biochem Biophys Acta. 1998; 1378: 79-113.
8. Heldin CH, Westermark B. Mechanism of action and in vivo role of platelets-derived growth factor. Physiol Rev. 1999; 79: 1283-1316.
9. Mantur M, Koper O. Płytkopochodny czynnik wzrostu (platelets-derived growth factor - PDGF): budowa, rola i jego receptory. Pol Merk Lek. 2008; 24: 173-176.
10. Tejada ML, Yu L, Dong J, et al. Tumor-driven paracrine platelets-derived growth factor receptor α signalling is a key determinant of stromal cell recruitment in a model of human lung carcinoma. Clin Cancer Res. 2006; 12: 2676-2688.
11. Suhardja A, Hoffman H. Role of growth factors and their receptors in proliferation of microvascular endothelial cells. Microsc Res Tech. 2003; 60: 70-75.
12. Kitadai Y, Sasaki T, Kuwai T, et al. Expression of activated platelets-derived growth factor receptor in stromal cell of human colon carcinomas is associated with metastatic potential. Int J Cancer. 2006; 119: 2567-2574.
13. Mantur M, Kemona H, Kozłowski R, et al. Effect of tumour stage and nephrectomy on CD62P expression and sP-selectin concentration in renal cancer. Neoplasma. 2003; 50: 262-265.
14. Bolewski A, Plewa R, Siminiak T. Udział czynników zapalnych w patogenezie miażdżycy. Pol Przeg Kard. 2003; 5: 61-69.
15. Fal AM, Jankowska A, Garstka H, et al. The role of adhesion molecules in the pathophysiology of diseases: Therapeutic prospects. Pol Arch Med Wewn. 2003; 1: 765-774.
16. Shikada Y, Yonemitsu Y, Koga T, et al. Platelets-derived growth factor-AA is an essential and autocrine regulator of vascular endothelial growth factor expression in non-small cell lung carcinomas. Cancer Res. 2005; 65: 7241-7248.
17. Starzyńska T, Wasilewicz MP. Chemioprewencja raka jelita grubego. Pol Merk Lek. 2007; 133: 70-73.
18. Hutter RV, Sobin LH. A universal staging system for cancer of the colon and rectum. Arch Pathol Lab Med. 1986; 110: 367-368.
19. Ross JA, Potter JD, Severson RK. Platelets-derived growth factor and risks factors for colorectal cancer. Eur J Cancer Prev. 1993; 2: 197-210.
20. Vincent L, Rafii S. Vascular frontiers without borders: muftifaceted roles of platelets-derived growth factor (PDGF) in supporting postnatal angiogenesis and lymphangiogenesis. Cancer Cell. 2004; 6: 307-309.
21. Filiberti R, Marroni P, Neri M. Serum PDGF-AB in pleural mesothelioma. Tumour Biol. 2005; 26: 221-226.
22. Yu J, Ustach C, Kim HR. Platelets-derived growth factor signalling and human cancer. J Biochem Mol Biol. 2003; 36: 49-59.
23. Małyszko J, Suchowierska E, Pawlak K. Platelets agregation and P-selectin concentration in patients on peritoneal dialysis treated with erythropoetin. Pol Arch Med Wewn. 2001; 3: 197-201.
24. Dymicka-Piekarska V, Matowicka-Karna J, Osada J, et al. Changes in platelets CD62P expression and soluble P-selectin concentration in surgically treated colorectal cancer. Adv Med Sci. 2006; 51: 304-308.
25. Mizia-Stec K, Mandecki T, Zahorska-Markiewicz B. P-selectin and E-selectin in serum of patients with coronary disease. Pol Arch Med Wewn. 2001; 6: 1137-1144.